UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044461
Receipt number R000050789
Scientific Title Development of Brain Machine Interface using deep brain electrode
Date of disclosure of the study information 2021/09/01
Last modified on 2022/06/14 17:46:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of Brain Machine Interface using deep brain electrode

Acronym

Development of Brain Machine Interface using deep brain electrode

Scientific Title

Development of Brain Machine Interface using deep brain electrode

Scientific Title:Acronym

Development of Brain Machine Interface using deep brain electrode

Region

Japan


Condition

Condition

Movement disorders

Classification by specialty

Neurology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Efficacy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Discrimination rates for motor type, emotion, and intention

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Parkinson's disease patients who have been or will be implanted with a implantable pulse generator capable of extracting local field potential

Sufficient motor and cognitive function to perform motor and cognitive tasks

Key exclusion criteria

Patients with declining cognitive function

Patients who have difficulty communicating

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Haruhiko
Middle name
Last name Kishima

Organization

Osaka University Graduate School of Medicine

Division name

Department of Neurosurgery

Zip code

5650871

Address

2-2 Yamadaoka, Suita City, Osaka, Japan

TEL

+81-(6)-6879-3652

Email

n-tani@nsurg.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Naoki
Middle name
Last name Tani

Organization

Osaka University Graduate School of Medicine

Division name

Department of Neurosurgery

Zip code

5650871

Address

2-2 Yamadaoka, Suita City, Osaka, Japan

TEL

+81-(6)-6879-3652

Homepage URL


Email

n-tani@nsurg.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Otemae Hospital

Osaka General Medical Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Clinical Research Review Committee

Address

2-2 Yamadaoka, Suita City, Osaka, Japan

Tel

+81-6-6210-8292

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学大学院医学系研究科脳神経外科


Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 06 Month 07 Day

Date of IRB

2021 Year 08 Month 31 Day

Anticipated trial start date

2021 Year 09 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Non-randomized non-blinded prospective case series study


Management information

Registered date

2021 Year 06 Month 07 Day

Last modified on

2022 Year 06 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050789